INSPRA
BGP PHARMA ULC
Quick answers
Is there a shortage of INSPRA in Canada?
No. There is no current shortage of INSPRA 25MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
APO-EPLERENONE
APOTEX INC
GD-EPLERENONE
GENMED A DIVISION OF PFIZER CANADA ULC
Other Products
INSPRA
BGP PHARMA ULC
JAMP EPLERENONE
JAMP PHARMA CORPORATION
MINT-EPLERENONE
MINT PHARMACEUTICALS INC
DIN
02323052
Strength
25MG
Dosage Form
Tablet
Route
Oral
Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from BGP PHARMA ULC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.